1-147552120-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_004326.4(BCL9):c.-478+10446C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.061 in 151,854 control chromosomes in the GnomAD database, including 423 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.061 ( 423 hom., cov: 32)
Consequence
BCL9
NM_004326.4 intron
NM_004326.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.135
Publications
5 publications found
Genes affected
BCL9 (HGNC:1008): (BCL9 transcription coactivator) BCL9 is associated with B-cell acute lymphoblastic leukemia. It may be a target of translocation in B-cell malignancies with abnormalities of 1q21. Its function is unknown. The overexpression of BCL9 may be of pathogenic significance in B-cell malignancies. [provided by RefSeq, Jul 2008]
BCL9 Gene-Disease associations (from GenCC):
- congenital heart diseaseInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.237 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BCL9 | NM_004326.4 | c.-478+10446C>T | intron_variant | Intron 1 of 9 | ENST00000234739.8 | NP_004317.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BCL9 | ENST00000234739.8 | c.-478+10446C>T | intron_variant | Intron 1 of 9 | 1 | NM_004326.4 | ENSP00000234739.3 | |||
| BCL9 | ENST00000683836.1 | c.-478+10446C>T | intron_variant | Intron 1 of 9 | ENSP00000506908.1 |
Frequencies
GnomAD3 genomes AF: 0.0610 AC: 9262AN: 151736Hom.: 424 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9262
AN:
151736
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0610 AC: 9259AN: 151854Hom.: 423 Cov.: 32 AF XY: 0.0625 AC XY: 4639AN XY: 74192 show subpopulations
GnomAD4 genome
AF:
AC:
9259
AN:
151854
Hom.:
Cov.:
32
AF XY:
AC XY:
4639
AN XY:
74192
show subpopulations
African (AFR)
AF:
AC:
1456
AN:
41382
American (AMR)
AF:
AC:
1416
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
AC:
66
AN:
3470
East Asian (EAS)
AF:
AC:
1275
AN:
5136
South Asian (SAS)
AF:
AC:
166
AN:
4824
European-Finnish (FIN)
AF:
AC:
527
AN:
10522
Middle Eastern (MID)
AF:
AC:
14
AN:
292
European-Non Finnish (NFE)
AF:
AC:
4172
AN:
67952
Other (OTH)
AF:
AC:
129
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
435
871
1306
1742
2177
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
387
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.